Literature DB >> 10567882

Uric acid urolithiasis and crystallization inhibitors.

F Grases1, M Ramis, A I Villacampa, A Costa-Bauzá.   

Abstract

An in vitro study of the inhibitory effects that some substances occasionally present in urine can provoke on the crystallization of uric acid has been performed. The most remarkable crystallization inhibitory effects were produced by mucine at concentrations of >0.5 mg/l. Pentosan polysulfate and chondroitin sulfate also clearly increased the uric acid crystallization times at concentrations of >100 mg/l. Saponins, such as escin and glycyrrhizic acid, also produced a notable delay in uric acid crystallization times at concentrations of >10 mg/l. Similar effects were observed in the presence of a surfactant substance, lauryl sulfate. N-Acetyl-L-cysteine caused crystallization perturbations only when it was present at concentrations of >50 mg/l. Citric acid and phytic acid caused no effects on uric acid crystallization even at the highest concentrations assayed (1,000 and 5 mg/l, respectively). From the results obtained it can be deduced that mainly glycoproteins, glycosaminoglycans and surfactant substances can exert protective effects against uric acid crystallization. Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567882     DOI: 10.1159/000030395

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  Identification of a new candidate locus for uric acid nephrolithiasis.

Authors:  M N Ombra; P Forabosco; S Casula; A Angius; G Maestrale; E Petretto; G Casu; G Colussi; E Usai; P Melis; M Pirastu
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  Effect of theobromine on dissolution of uric acid kidney stones.

Authors:  Francesca Julià; Antonia Costa-Bauza; Francisco Berga; Felix Grases
Journal:  World J Urol       Date:  2022-06-11       Impact factor: 3.661

3.  Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis.

Authors:  Concepción Sáez-Torres; Félix Grases; Dolores Rodrigo; Ana María García-Raja; Cristina Gómez; Guillem Frontera
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

4.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007

5.  Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.

Authors:  Felix Grases; Adrian Rodriguez; Antonia Costa-Bauza
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 6.  Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review.

Authors:  A Abou-Elela
Journal:  J Adv Res       Date:  2017-04-28       Impact factor: 10.479

Review 7.  Advances in Ureteral Stent Design and Materials.

Authors:  Ali Mosayyebi; Costantino Manes; Dario Carugo; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2018-04-10       Impact factor: 3.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.